Primary Care Providers' Experiences With an Active Elective Genetic Testing Program

• Published in: Health education & behavior 2024-07, p.10901981241266849
• Main Authors: Platt, Dylan M, Blout Zawatsky, Carrie L, Christensen, Kurt D, Green, Robert C, Hajek, Catherine, Hickingbotham, Madison R, Hutchinson, Allison M, LeBlanc, Jessica L, Zoltick, Emilie S, Jamal, Leila
• Format: Article
• Language: English
• ISSN: 1090-1981; 1552-6127; 1552-6127
• DOI: 10.1177/10901981241266849

Elective genetic testing (EGT) programs that provide pharmacogenomic information to guide medication management and screen for medically actionable disease predispositions are emerging in a number of health systems. Primary care providers (PCPs) are at the forefront of test initiation, patient education, and management of EGT results. However, little research has examined the experiences of PCPs in health systems offering clinical EGT. We conducted semi-structured interviews, a sub-study of the larger mixed-methods Imagenetics Initiative, with 16 PCPs at a health system in the Midwest with a clinical EGT program supported by provider education, automated clinical decision support, and enhanced access to genetic specialists. The purpose of these interviews was to understand perceptions about the benefits and barriers of implementing EGT in clinical practice. Thematic analysis indicated that EGT is conceptualized similar to traditional diagnostic services. PCPs were generally favorable toward EGT; however, targeted education did not dispel misconceptions about the goals, results, and limitations of EGT. Most PCPs endorsed the potential utility of EGT. Pharmacogenomic profiling was seen as having more immediate impact for patients than screening for monogenic disease risks. PCPs reported that they weighed discussions about EGT against time limitations and the need to prioritize patients' existing health concerns. Regardless of their education levels and familiarity with genetics, PCPs desired additional educational resources and greater access to genetic specialists. Our study provides unique insight into PCPs' experiences with clinical EGT in health systems that have adopted EGT and highlights the practical challenges and potential opportunities of EGT integration.